Search

Pulse Biosciences Inc

Suletud

SektorTervishoid

53.18 1.01

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

53.18

Max

54.54

Põhinäitajad

By Trading Economics

Sissetulek

-6.1M

-25M

Müük

33K

434K

Aktsiakasum

-0.36

Kasumimarginaal

-5,681.336

Töötajad

116

EBITDA

-5.5M

-24M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+17.57% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

5. nov 2026

Turustatistika

By TradingEconomics

Turukapital

780M

3.4B

Eelmine avamishind

52.17

Eelmine sulgemishind

53.18

Pulse Biosciences Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

23. okt 2026, 20:07 UTC

Pulse Biosciences Inc shares are advancing, continuing an upward trend since Thursday, despite earlier pulling back from a session high.

22. okt 2026, 20:07 UTC

Pulse Biosciences Inc shares advanced, reflecting a broader upward trend in the market, which has seen a cumulative return of 2.87% since Wednesday's close.

21. okt 2026, 20:07 UTC

Pulse Biosciences Inc is trading modestly higher, aligning with significant overall market gains, and remains above its 20-day moving average.

20. okt 2026, 22:11 UTC

Pulse Biosciences Inc shares declined in after-market trading, following a notable drop at Tuesday's close amid weakness in the Health Care Equipment sub-sector.

16. okt 2026, 20:07 UTC

Pulse Biosciences Inc shares declined significantly, finishing well below their 20-day moving average after a downward trend that began Thursday.

15. okt 2026, 20:07 UTC

Pulse Biosciences Inc shares fell sharply, marking the fifth consecutive session of declines, closing significantly below its 20-day moving average.

14. okt 2026, 21:51 UTC

Pulse Biosciences Inc is trading lower in after-market hours, continuing a trend of three consecutive lower closes amid broader market declines following rising inflation.

13. okt 2026, 20:01 UTC

Social Media

Oppenheimer raises its price target on Pulse Biosciences Inc to 60 from 35 while maintaining an Outperform rating after a non-deal roadshow.

12. okt 2026, 20:06 UTC

Pulse Biosciences Inc shares are declining, continuing a downward trend since Friday.

9. okt 2026, 22:20 UTC

Pulse Biosciences Inc shares are declining in after-market trading, hitting their lowest point since Friday's close after a brief opening gain.

7. okt 2026, 20:07 UTC

Event

Shares of Pulse Biosciences Inc are declining despite the successful enrollment of 164 patients in its NANOPULSE-AF Study, remaining below its 20-day moving average.

5. okt 2026, 20:06 UTC

Pulse Biosciences Inc is advancing, continuing its upward trend since Friday, despite an earlier pullback from a session high. The health care equipment sector shows notable gains.

2. okt 2026, 20:07 UTC

Pulse Biosciences Inc shares fell sharply, closing at their lowest point amid broader market weakness and trading below the 20-day moving average.

1. okt 2026, 20:07 UTC

Pulse Biosciences Inc shares fell sharply, pulling back from a morning peak and remaining below its 20-day moving average.

30. sept 2026, 21:01 UTC

Pulse Biosciences Inc closed lower in after-market trading, marking its fourth consecutive session of decline and remaining significantly below its 20-day moving average.

29. sept 2026, 21:21 UTC

Pulse Biosciences Inc has declined in after-market trading, moving lower since Tuesday's close and falling below its 20-day moving average.

28. sept 2026, 22:21 UTC

Pulse Biosciences Inc saw a significant increase in after-market trading, reaching a notable peak and remaining well above its 20-day moving average.

25. sept 2026, 20:07 UTC

Pulse Biosciences Inc shares fell modestly as the broader market declined, continuing a trend of five consecutive sessions finishing lower.

24. sept 2026, 20:07 UTC

Pulse Biosciences Inc. shares fell sharply, continuing a trend of declines over the last four sessions after an earlier gain in the current session.

23. sept 2026, 19:25 UTC

Pulse Biosciences Inc shares fell modestly, continuing a downward trend observed over the past three sessions, despite initially rising sharply after the market opened.

22. sept 2026, 19:34 UTC

Pulse Biosciences Inc shares fell sharply, declining from Monday's close despite remaining above the 20-day moving average and within the one-month range.

21. sept 2026, 20:12 UTC

Pulse Biosciences Inc declined in after-market trading following Monday's close, remaining flat throughout the session but positioned above its 20-day moving average.

18. sept 2026, 20:02 UTC

Pulse Biosciences Inc shares are rising sharply, reaching a notable high and trading above its 20-day moving average with unusually high volume.

17. sept 2026, 20:07 UTC

Pulse Biosciences Inc is gaining, reflecting positive movement in the health care equipment sector, despite pulling back from an earlier session high.

16. sept 2026, 23:36 UTC

Pulse Biosciences Inc is declining in after-market trading, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

15. sept 2026, 22:02 UTC

News
Event

Pulse Biosciences has an $85 million equity distribution agreement with Mizuho. Shares are trading lower in after-market hours following the announcement.

14. sept 2026, 20:08 UTC

Pulse Biosciences Inc shares are higher today, maintaining a strong position since Friday's close and peaking significantly above the 20-day moving average.

11. sept 2026, 20:08 UTC

Pulse Biosciences Inc is declining in Friday's trading session, continuing a downward trend since Thursday. The stock remains above its 20-day moving average.

10. sept 2026, 20:01 UTC

Pulse Biosciences Inc shares are higher today amid strong trading volume. The stock remains above its 20-day moving average, reflecting broader market trends.

9. sept 2026, 22:01 UTC

Pulse Biosciences shares moved higher in after-market trading, remaining above the 20-day moving average and near the upper end of their one-month range.

Võrdlus sarnastega

Hinnamuutus

Pulse Biosciences Inc Prognoos

Hinnasiht

By TipRanks

17.57% tõus

12 kuu keskmine prognoos

Keskmine 62.333 USD  17.57%

Kõrge 73 USD

Madal 55 USD

Põhineb 6 Wall Streeti analüütiku instrumendi Pulse Biosciences Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

6 ratings

6

Osta

0

Hoia

0

Müü

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
help-icon Live chat